RENEE SPENCER: Open Payments
NPI 1598458853 · WINDER, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$961 in 48 payments from 18 companies in 2025. Trend: 2023 $791 · 2024 $708 · 2025 $961
Food & beverage: $901Education: $60
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $163 |
| Novo Nordisk Inc | 11 | $154 |
| SANOFI-AVENTIS U.S. LLC | 4 | $107 |
| GlaxoSmithKline, LLC. | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| Lilly USA, LLC | 3 | $56 |
| Amgen Inc. | 3 | $45 |
| ABBVIE INC. | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
Products named: TZIELD, Veozah, Wegovy, REXULTI, GEMTESA, TRELEGY ELLIPTA, SHINGRIX, Ozempic.
Industry payments across GA — which companies pay providers there.
